Calcium Acetate Control of Serum Phosphorus in Hemodialysis Patients-Reference-Cited by-同舟云学术

Calcium Acetate Control of Serum Phosphorus in Hemodialysis Patients

Published:1991-05 Issue:5 Volume:17 Page:544-550
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Emmett Michael,Sirmon Maryella D.,Kirkpatrick Wanda G.,Nolan Charles R.,Schmitt Gunther W.,Cleveland Mark vB.

Publisher

Elsevier BV

Subject

Nephrology

Reference23 articles.

1. The absorption of dietary phosphorus and calcium in hemodialysis patients;Ramirez;Kidney Int,1986

2. The influence of a high calcium carbonate intake on bone disease in patients undergoing hemodialysis;Meyrier;Kidney Int,1973

3. Calcium carbonate, an aluminum-free agent for control of hyperphosphatemia, hypecacemia, and hyperparathyroidism in uremia;Fournier;Kidney Int,1986

4. Effects of high CaCO3 supplements on serum calcium and phosphorus in patients on regular hemodialysis treatment;Gonella;Clin Nephrol,1985

5. Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing hemodialysis;Slatopolsky;N Engl J Med,1986

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Directions in Phosphorus Management in Dialysis;Journal of Renal Nutrition;2023-01

2. Phosphate Frustration: Treatment Options to Complement Current Therapies;International Journal of Nephrology;2022-08-22

3. Calcium, phosphate, PTH, vitamin D, and FGF-23 in CKD-mineral and bone disorder;Nutritional Management of Renal Disease;2022

4. Effectiveness of phosphate binders in adult patients with end stage renal disease receiving hemodialysis;JBI Database of Systematic Reviews and Implementation Reports;2019-01

5. Mineral Bone Disorders in Chronic Kidney Disease;Chronic Kidney Disease, Dialysis, and Transplantation;2019